Workshop Summary
The Food and Drug Administration (FDA) proposes to award a firm-fixed-price purchase order on a sole source basis to the Institute of Medicine (IOM) of the National Academy of Sciences (NAS). The Institute of Medicine (IOM) convened public workshops on February 12 and May 12, 2014. A key work product of these workshops is a meeting summary report that will be published by IOM to the general public approximately 8-10 months following the workshops. A written summary of the meetings' proceedings is critical to ensuring progress in the important area of structured approaches to benefit-risk assessment, which is a high priority for FDA, the regulated industry, and Congress. Without this written analysis, which only IOM can provide, continued progress in advancing the agency's work and adequately addressing Sec. 905 of the FDA Safety and Innovation Act of 2012 would be negatively impacted.
This contract action is for supplies or services which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1 (b) and 10 U.S.C. 2304(c).
Interested persons may identify their interest and capability to respond to the requirement or submit quotations. This notice of intent is not a request for competitive quotations; however, all quotations and responses received within the fifteen (15) days of issuance of this notice will be considered by the government. A determination by the government not to compete this proposed purchase order based upon responses to this notice are solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Sonia J. Nance, Contract Officer , Phone 2404027605, Email [email protected] - James G. Whitt, Contracting Officer, Phone 2404027627, Email [email protected]
